Investigative Site 10 — Paris

Public research footprint of Investigative Site 10, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia… · Cardiovascular Disease and Lipoprotein(a) · Primary Prevention of Atherosclerotic Cardiovascular Disease · Non Small Cell Lung Cancer

Recently updated registry entries

NCT07517263 — An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate… (Recruiting)
NCT05739383 — A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention… (Active Not Recruiting)
NCT04928846 — A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Investigative Site 10?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.